GOP Sens. Knock 'Opaque' FDA Stand On Biosimilars
High-ranking Senate Republicans on Thursday voiced displeasure with the U.S. Food and Drug Administration's cautious pace in publishing guidance on numerous policies related to biosimilars, accusing the agency of generating confusion...To view the full article, register now.
Already a subscriber? Click here to view full article